News Conference News EuroPCR 2022 JenaValve Trilogy Meets the Challenge of AR in Early Real-World Use Caitlin E. Cox May 18, 2022
News Conference News EuroPCR 2022 Changes in Cardiac Damage After AVR Tied to 2-Year Outcomes Caitlin E. Cox May 17, 2022
News Conference News ACC 2022 ADAPT-TAVR: Edoxaban No Better Than DAPT After TAVI Todd Neale April 05, 2022
News Conference News ACC 2022 Self-Expanding TAVI Looks More Durable Than SAVR at 5 Years Michael O'Riordan April 04, 2022
News Conference News ACC 2022 APOLLO: Novel siRNA Injectable Cuts Lp(a) by Nearly 100% in Small Study Michael O'Riordan April 03, 2022
News Conference News ACC 2022 New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More Shelley Wood April 01, 2022
News Conference News Longer-Term LRT Results ‘Encouraging’ for TAVI in Low-risk Patients Todd Neale March 01, 2022
News Conference News THT 2022 LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety Caitlin E. Cox February 02, 2022
News Conference News STS 2022 Bicuspid SAVR Outcomes Meet or Beat Tricuspid in STS Database L.A. McKeown February 02, 2022
News Conference News PCR London Valves 2021 Good Results but Small Numbers With JenaValve Trilogy in Severe AR Michael O'Riordan November 26, 2021
News Conference News AHA 2021 AVATAR Supports Early SAVR in Asymptomatic Severe AS Patients L.A. McKeown November 13, 2021
News Conference News TCT 2021 TAVI Edges Out Surgery in 2-Year Costs for Low-risk Patients: PARTNER 3 Yael L. Maxwell November 05, 2021
News Conference News TCT 2021 SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years Todd Neale November 05, 2021
News Conference News EACTS 2021 More Deaths With Bioprosthetic Than Mechanical AVR in Young AS Patients Michael O'Riordan October 18, 2021
News Conference News ESC 2021 PET Imaging Detects Degeneration After TAVI as Well as Surgical, Native Valves Yael L. Maxwell September 02, 2021
News Conference News ESC 2021 2021 ESC/EACTS Valve Guidelines Unveil TAVI/SAVR Age Cutoffs and Earlier Care Shelley Wood August 31, 2021
News Conference News ESC 2021 New ESC HF Guidelines Showcase SGLT2 Inhibitors, Tafamidis, Vericiguat, and COAPT Shelley Wood August 28, 2021
News Conference News ESC 2021 ENVISAGE-TAVI AF: Edoxaban Disappoints in TAVI Setting Todd Neale August 28, 2021
News Conference News TVT 2021 Post-TAVI Pacemaker Rates Down in the US, but ‘Still Quite High’ Todd Neale July 23, 2021
News Conference News TVT 2021 TAVI Outcomes Similar in Low-Risk Bicuspid, Tricuspid Aortic Stenosis at 1 Year Todd Neale July 20, 2021